On September 11, Nuclei Smart Fusion Semiconductor Technology (Shanghai) Co., Ltd. (with the stock ticker 'Nuclei Technology' and stock code 875127) successfully registered for listing guidance with the Shanghai Securities Regulatory Bureau. This move officially kicks off its journey towards an Initial Public Offering (IPO) of A-shares, with China Merchants Securities serving as its guidance institution. The company entered into a guidance agreement with China Merchants Securities on September 8, submitted its application for listing guidance on September 9, and has set its sights on listing on the Beijing Stock Exchange.

Established in 2018, Nuclei Technology is dedicated to the research and development, as well as the industrial application, of core CPU technologies based on the RISC-V architecture. Its primary offerings encompass RISC-V CPU IP licensing, SoC subsystem platform licensing, and tailored chip solutions. These products find applications across a wide range of sectors, including automotive electronics, industrial control, artificial intelligence, and data centers.

The company boasts an impressive portfolio of 93 authorized patents within China and has cultivated a client base of over 300, which includes several listed companies and central and state-owned enterprises. Despite experiencing negative net profits in 2024 and 2025, Nuclei Technology has demonstrated robust revenue growth, achieving RMB 36.8745 million in revenue during the first half of 2026.